AMWatch

Novo Holdings' indtjening blev næsten halveret i 2018

Mens Novo Holdings formår at score gevinster på sine aktiver i Novo Nordisk og Novozymes, så er afkastet fra life science-investeringerne og de finansielle investeringer dårligere end sidste år og derfor er indtjeningen næsten halveret.

Photo: Novo Holdings/PR

Sidste års aktieuro har sat sine tydelige spor i investeringsselskabet Novo Holdings' resultater.

For mens pengetanken bag Novo Nordisk formår at indkassere et positivt afkast, så lyder det på blot 1 pct., hvilket er væsentligt mindre end det, selskabet kunne præsentere i sin årsrapport for 2017.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from AMWatch

The ESG market is controlled by a few big investors

Finland's largest investor holds 62 percent of shares of multi-trillion ETFs offered by iShares and 64 percent of Xtrackers' equivalent offering. Having a few investors dominating ownership in this way is not good for the vehicles' liquidity and could be a big challenge facing the sector.

"We continue to see further growth in our Nordic book of business"

DECEMBER SERIES: What were the most important developments at some of the global asset managers present on the Nordic market in 2021, and what are their expectations for the coming year? AMWatch's December series is kicked off by Head of Nordics at State Street Global Advisors, Arnaud Bruyneel. 

Related articles

Latest news

Jobs

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch